Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, July 1, 2025.
Atea Pharmaceuticals, Inc. - common stock (NASDAQ:AVIR)
Long-Term Uptrend (+90) - AVIR is in a strong uptrend that is likely to continue. While AVIR is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid AVIR?
MarketClub looks at technical strength and momentum to determine if the timing is right for AVIR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for AVIR
The long-term trend has been UP since Jun 10th, 2025 at 3.2900
The intermediate-term trend has been UP since May 27th, 2025 at 3.0100
The short-term trend has been UP since Jun 17th, 2025 at 3.2793
Smart Scan Analysis for AVIR
Based on our trend formula, AVIR is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 3.570 | 3.650 | 3.535 | 3.590 | -0.010 |
| Prev. Close | Volume | Bid | Ask | Time |
| 3.600 | 334263 | 2025-07-01 15:59:58 |
| 52wk High | 4.145 | 52wk High Date | 2024-09-17 |
| 52wk Low | 2.455 | 52wk Low Date | 2025-05-15 |
| Average Volume | 425,358 | Shares Outstanding | 85,579 |
| Assets | 439,964,000M | Liabilities | 28,880,000M |
| P/E Ratio | 10.1515 |